All Vaccinology articles – Page 2
-
NewsCase report shows mpox breakthrough infection in man who had received both vaccine doses
New research details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a ‘breakthrough’ mpox infection in January 2024.
-
NewsStudy shows Mpox (monkeypox) antibodies wane within a year of vaccination
New research shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination.
-
NewsSignificant decline of neutralising antibodies to monkeypox virus during the first month after vaccination
New research shows that even in men who receive two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.
-
NewsTB vaccine may enable elimination of the disease in cattle by reducing its spread
Vaccination not only reduces the severity of TB in infected cattle, but reduces its spread in dairy herds by 89%, research finds.
-
NewsInsights from patient who cleared hepatitis C could lead to vaccine
By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.
-
NewsNew vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
In a mouse study, researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease, which is endemic in many tropical areas.
-
NewsNew study provides insights into COVID-19 vaccine uptake among children and young people
COVID-19 vaccine uptake among children and young people was low across all four UK nations, compared to other age groups, according to the first research study to look at data from all four UK nations.
-
NewsCommunity-based cohort study to track short- and long-term effects of multiple respiratory viruses
Scientists are initiating a critical two-year prospective epidemiologic study in the spring of 2024 to track acute respiratory infections across the United States.
-
NewsAddressing both flu and COVID-19 through a single, multitasking injection
A study found a protein triggered the influx of acquired T cells and the proliferation of innate-like T cells in the lungs, which mounted a swift and comprehensive defense against a broad spectrum of pathogens.
-
NewsPowerful new AI can predict people’s attitudes to vaccines
A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics and personal judgments such as aversion to risk or loss.
-
NewsStudy maps main genes involved in immune response to infection by dengue virus
Researchers compared data for the immune response induced by natural infection and vaccines. They identified the key factors in the development of long-lasting immunity.
-
NewsIVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
-
NewsNew nasal vaccine platform helps clear COVID-19 infections in an animal model
Researchers demonstrate proof-of-principle of a protein-based platform, called SpyCage, that could eventually help to prevent infection and transmission of respiratory viruses, like SARS-CoV-2.
-
NewsStudy indicates need for typhoid conjugate vaccines in endemic countries
A new study calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.
-
NewsStudy reveals low COVID-19 transmission rate from mothers to newborns
COVID-19 vaccination reduces risks of severe outcomes in pregnant women, who show fewer harmful effects from the Omicron variant, a study shows. It also reveals that COVID-19 transmission from mothers to their newborns is low.
-
NewsVaccine monitoring crucial as SARS-CoV-2 variants continue to evolve
Researchers compared the newer monovalent COVID vaccine, which specifically targets the XBB variant of Omicron, with older bivalent vaccines containing a mix of an Omicron variant and the original strain of COVID-19.
-
NewsCOVID vaccines are safe for pregnant women and babies
The COVID vaccine is safe to administer during pregnancy, reports a new study in an important finding on the safety of the vaccine in infants – despite widespread fear and misinformation.
-
News$12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza
The Access to Advanced Health Institute (AAHI) has been awarded the first stage of funding for a $12.7-million project to develop a novel immune-stimulating adjuvant formulation that will improve the human immune response to vaccines.
-
NewsScientists show how COVID mRNA vaccines reshape immune memory after each dose
Researchers show that T cells can reshape their memory and maintain diversity against different COVID variants in response to successive mRNA vaccinations.
-
NewsWomen with high-risk HPV and metabolic syndrome have almost three times risk for mortality
Women with both metabolic syndrome and high-risk strains of human papillomavirus (HPV) are at a 2.6 times higher risk for mortality than women without either condition.
